# Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19

> **NCT04425863** · — · COMPLETED · sponsor: **Eurnekian Public Hospital** · enrollment: 167 (actual)

## Conditions studied

- Severe Acute Respiratory Syndrome
- Ventilation Pneumonitis

## Interventions

- **DRUG:** Ivermectin 5 MG/ML oral solution, Aspirin 250 mg tablets
- **OTHER:** Ivermectin 5 mg/mL oral solution, Dexamethasone 4-mg injection, Aspirin 250 mg tablets
- **OTHER:** Ivermectin 5 MG/ML oral solution, Dexamethasone 4-mg injection, Enoxaparin injection. Inpatient treatment with mechanical ventilation in ICU.

## Key facts

- **NCT ID:** NCT04425863
- **Lead sponsor:** Eurnekian Public Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-01
- **Primary completion:** 2020-08-30
- **Final completion:** 2020-08-30
- **Target enrollment:** 167 (ACTUAL)
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04425863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04425863, "Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04425863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*